You are here

DEVELOPMENT OF AN ELISA TEST FOR ANTIBODIES TO HUMAN B-LYMPHOTROPHIC VIRUS

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: N/A
Agency Tracking Number: 7102
Amount: $50,000.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 1987
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
1600 East Gude Drive
Rockville, MD 20850
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 ANNE J BODNER PHD
 (301) 251-0800
Business Contact
Phone: () -
Research Institution
N/A
Abstract

NIH RESEARCHERS HAVE RECENTLY ANNOUNCED THE ISOLATION OF A HUMAN B-LYMPHOTROPIC VIRUS (HBLV) FROM SIX INDIVIDUALS WITH VARIOUS LYMPHOPROLIFERATIVE AND IMMUNE DISORDERS. HBLV APPEARS TO BELONG TO THE GROUP OF HUMAN HERPES VIRUSES AND MAY BE ASSOCIATED WITH B LYMPHOPROLIFERATIVE DISORDERS. EARLY SEROLOGICAL TESTS USING INDIRECT IMMUNOFLUORESCENCE METHODS REVEALED THAT ONLY 4 OF 220 RANDOM, HEALTHY BLOOD DONORS WERE SEROPOSITIVE FOR HBLV ANTIBODIES. MORE RECENT REPORTS STATE THAT THE PREVALENCE OF HBLV INFECTION MAY BE HIGHER. AN ELISA-BASED ASSAY FOR HBLV ANTIBODY DETECTION WOULD FACILITATE FURTHER STUDY OF THE PREVALENCE OF INFECTION WITH THIS VIRUS AND THE RELATION OF INFECTION TO HUMAN DISEASE. HBLV HAS BEEN SEEN TO BE INFECTIOUS IN SEVERAL CELL LINES ASWELL AS IN FRESH B LYMPHOCYTES. IN THIS PROPOSAL, BIOTECH RESEARCH LABORATORIES, INC. PRESENTS ITS PLAN FOR USING HBLVCULTURED IN THE HSB-2 CELL LINE TO DEMONSTRATE THE FEASIBILITY OF DEVELOPING AN ELISA-BASED TEST KIT FOR HBLV ANTIBODY DETECTION.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government